Life Science Investing Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
Life Science Investing Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
Life Science Investing Profound Medical to Participate in Lake Street's 9th Annual Best Ideas Growth Conference
Locksley Announces Major Advancement at Mojave as Structural Mapping Expands Scale of Antimony Target with a 400% Increase in Target Strike Length
